Beckman and BioSepra form marketingand service alliance for protein purification products.FULLERTON, Calif.--(BUSINESS WIRE)--March 14, 1995--Beckman Instruments Inc. (NYSE NYSE See: New York Stock Exchange :BEC) Tuesday announced the formation of a strategic alliance with BioSepra, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BSEP BSEP Bile Salt Export Pump BSEP Basic Skills Education Program BSEP Black Sea Environmental Program ) of Marlborough, Mass. In combination, the two companies will offer systems for high speed, high resolution separation of biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page in configurations useful for research, development and biopharmaceutical production. Beckman will serve customers working in research and methods development, while BioSepra will focus on larger scale production-based applications. Under this agreement, Beckman obtains exclusive rights to market and sell BioSepra's patented HyperDiffusion Chromatography media, trademarked HyperD, in prepacked columns designed for bioresearch bi·o·re·search n. Research in the biological sciences. . The HyperD media combines the high protein binding capacity of soft gels with high flow advantages of rigid porous porous /por·ous/ (por´us) penetrated by pores and open spaces. po·rous adj. 1. Full of or having pores. 2. Admitting the passage of gas or liquid through pores. materials. The alliance also includes a provision for Beckman to distribute and service BioSepra's new process development workstation, ProSys, and other systems under development for research and methods development. The ProSys workstation is optimized for use with HyperD providing the ability to design methods and optimize process separations. "Our alliance with BioSepra complements Beckman's long-term focus on improving laboratory productivity for biotechnology based processes," said Beckman Chairman and Chief Executive Officer Louis T. Rosso. "BioSepra's innovative products will allow our pharmaceutical and biotechnology customers to easily move protein-based drugs from research into production by using the same scalable media." Jean-Marie Vogel, president and chief executive officer of BioSepra, said, "With the help of one of the world's largest sales and support organizations in the bioresearch market, BioSepra can now access the front end of the biopharmaceutical research market. This will give us more opportunities to be chosen as a scale-up partner in the downstream process market segment where we now compete." BioSepra is a manufacturer of bioseparation systems, columns, and chromatographic chro·mat·o·graph n. An instrument that produces a chromatogram. tr.v. chro·mat·o·graphed, chro·mat·o·graph·ing, chro·mat·o·graphs To separate and analyze by chromatography. media used for the development and production of biopharmaceutical products. The company is a leading supplier of products for research through production of biopharmaceuticals. Beckman Instruments Inc. is a registered ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9000 Quality Systems company which develops, manufactures and markets automated systems and supplies used for biological analysis in laboratories for research, product development and clinical diagnostics. Beckman operates in more than 120 countries. -0- Note to Editors: HyperDiffusion, HyperD, and ProSys are trademarks of BioSepra Inc. CONTACT: Beckman Instruments, Fullerton Jay Steffenhagen, 714/773-7764; 714/773-8111 (fax) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion